WHO Issues Alert Over Critical Scarcity of Weight-Loss Injections

Fewer than 10% of patients who could benefit from weight-loss injections like Wegovy have access to them, warns the global health agency as it publishes its first recommendations on the therapies.

Given in excess of 1,000,000,000 individuals worldwide currently obese, it is advocating for increased and just access to these injectable treatments.

According to forecasts, in excess of 2,000,000,000 are projected to be living with obesity by 2030 without intervention.

"The latest guidelines recognises that obesity is a lifelong illness that can be treated with thorough and ongoing treatment," stated its chief Tedros Adhanom Ghebreyesus.

Substantial prices, limited production capacity, and distribution challenges are major obstacles to broad access to the jabs that can assist patients in reducing considerable body mass, explains the body.

GLP-1 Therapy Scarcity

Even under the current most favorable outlook, the manufacturing of such drugs would only suffice for around 100 million people – less than 10% of those who need them, as stated by the health organization.

The guideline calls on nations and manufacturers to expand availability, through strategies such as licensing agreements.

The intellectual property rights on a key compound – the main ingredient of a leading brand – is set to lapse in multiple nations in 2026.

How Weight-Loss Jabs Work

GLP-1 drugs mimick a body's own hormone to slow digestion, reduce hunger and enhance satiety so individuals consume fewer calories.

People typically begin shedding pounds within a few weeks of starting on the weekly injections.

Research indicates users may put most of the weight back on a year later of halting the medication, when their normal food cravings resume.

Being carrying excess weight increases your chance for developing diseases, like diabetes, cardiovascular issues, stroke, and specific malignancies.

Excess weight impacts individuals in all nations and was responsible for millions of deaths worldwide in 2024, according to the WHO.